Clinical Trial Update: Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1 [Phase 3]

View source ↗

Summary

Phase 3 trial updating treatment-experienced, multi-drug resistant HIV-1 patients with ibalizumab plus an optimized background regimen completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ibalizumab (ibalizumab)

Snippet

Sponsor: TaiMed Biologics Inc. | Conditions: HIV | Phase 3 | Status: COMPLETED | Results posted: 2021-03-11